Tyme Technologies Operating Cash Flow 2011-2026 | TYME

Annual Operating Cash Flow Tyme Technologies

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-23.6 M	-19.6 M	-20.1 M	-11.9 M	-5.86 M	-	-6.61 M	-57.7 K	-47.5 K	-27.4 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-27.4 K	-23.6 M	-9.75 M

Quarterly Operating Cash Flow Tyme Technologies

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-4.78 M	-	-	-14 M	-5.81 M	-	-	-18.5 M	-12.8 M	-6.39 M	-	-13.9 M	-9.57 M	-5.6 M	-5.2 M	-16.1 M	-10.9 M	-	-	-	-2.75 M	-	-	-	-	-1.37 M	-	-	-	-1.94 M	-	-	-53.1 K	-120 K	-	-19 K	-19 K	-7.24 K	-	-26 K	-12.9 K	-2.69 K	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-2.69 K	-18.5 M	-5.65 M

Operating Cash Flow of other stocks in the Biotechnology industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-481 M	-	2.43 %	$ 254 M	Germany
Ultragenyx Pharmaceutical RARE	-466 M	$ 19.23	-3.85 %	$ 1.9 B	USA
ARCA biopharma ABIO	-57.8 M	-	1052.0 %	$ 415 M	USA
RedHill Biopharma Ltd. RDHL	-65 M	$ 0.8	0.89 %	$ 428 M	Israel
Dr. Reddy's Laboratories Limited RDY	35.7 B	$ 13.56	-1.56 %	$ 2.25 B	India
Regeneron Pharmaceuticals REGN	4.98 B	$ 742.02	-1.94 %	$ 77.6 B	USA
Aeterna Zentaris AEZS	-8.58 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-18 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-169 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	-15.1 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	-63.7 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	-230 M	-	-	$ 3.67 B	USA
I-Mab IMAB	-1.3 B	-	-	$ 866 M	China
Genfit SA GNFT	99.9 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	-108 M	-	-0.23 %	$ 916 M	USA
Replimune Group REPL	-192 M	$ 7.22	-4.24 %	$ 582 M	USA
Biophytis SA BPTS	-23.8 M	-	-13.47 %	$ 169 M	France
REGENXBIO RGNX	-124 M	$ 7.88	-4.6 %	$ 406 M	USA
Aileron Therapeutics ALRN	-19.4 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	-59.7 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	-6.01 M	-	-18.52 %	$ 27.3 M	Britain
Arena Pharmaceuticals ARNA	-452 M	-	-6.81 %	$ 3.04 B	USA
Rigel Pharmaceuticals RIGL	75.7 M	$ 26.2	-0.64 %	$ 471 M	USA
Applied Genetic Technologies Corporation AGTC	-65.7 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	-9.03 M	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	-34.5 M	-	-	$ 7.46 M	Israel
Atreca BCEL	-80.7 M	-	-11.76 %	$ 5.79 M	USA
Avidity Biosciences RNA	-650 M	$ 13.09	-0.08 %	$ 1.8 B	USA
Acorda Therapeutics ACOR	-14 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	-235 M	-	-	$ 546 M	USA
Acasti Pharma ACST	-14.9 M	-	4.01 %	$ 150 M	Canada
Avid Bioservices CDMO	11 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	-92.5 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-30.3 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-29.5 M	-	-9.65 %	$ 45.9 M	USA
Rhythm Pharmaceuticals RYTM	-116 M	$ 78.52	-4.13 %	$ 5.1 B	USA
Adaptive Biotechnologies Corporation ADPT	-46 M	$ 12.57	-9.96 %	$ 1.91 B	USA
Sana Biotechnology SANA	-144 M	$ 2.78	-8.42 %	$ 704 M	USA
BeiGene, Ltd. BGNE	1.13 B	-	0.49 %	$ 251 B	Cayman-islands
SIGA Technologies SIGA	43.5 M	$ 5.35	7.76 %	$ 383 M	USA
Alnylam Pharmaceuticals ALNY	524 M	$ 321.71	-1.96 %	$ 42.1 B	USA
BioDelivery Sciences International BDSI	41 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	-92.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-75.6 M	-	-	$ 3.74 B	USA
Silence Therapeutics plc SLN	6.81 M	$ 4.8	-9.6 %	$ 622 M	Britain
Enlivex Therapeutics Ltd. ENLV	-13 M	$ 1.08	-0.92 %	$ 22.2 M	Israel
Enochian Biosciences ENOB	-7.87 M	-	-	$ 40.5 M	USA